(Total Views: 593)
Posted On: 01/07/2021 3:41:46 PM
Post# of 148903
Re: MD VIROLOGIST #71755
Quote:
in rantes driven COVID, it is very different.
What would make a difference is the level of expression of CCR5. In that case the drug with the higher level of occupancy would have greater effect.
Quote:
If anything even in HIV Mav could be superior in binding only a head to head study would resolve that hypothesis.
With the same MOA what would be indicative of CCR5 occupancy would be the efficacy. Leronlimab has clearly superior efficacy.
(8)
(0)Scroll down for more posts ▼
